Condensed Consolidated Statements of Convertible Preferred Stock and Stockholders' Equity (Deficit) - USD ($) $ in Thousands		Total	Preferred Stock Convertible Preferred Stock	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Accumulated Comprehensive (loss) Income
Balance, before retroactive conversion		$ (55,692)	$ 87,140	$ 2	$ 6,521	$ (62,215)
Retroactive application				$ (1)	1
Retroactive application, shares	[1]		(152,677,720)	(17,972,432)
Balance, before retroactive conversion, shares	[1]		199,145,285	23,442,353
Beginning balance at Dec. 31, 2022		(55,692)	$ 87,140	$ 1	6,522	(62,215)
Beginning balance, shares at Dec. 31, 2022	[1]		46,467,565	5,469,921
Issuance of common stock upon exercise of stock options		92			92
Issuance of common stock upon exercise of stock options, shares	[1]			140,545
Stock-based compensation expense		366			366
Issuance of common stock in connection with the acquisition of fSight		10,077			10,077
Issuance of common stock in connection with the acquisition of fSight, shares	[1]			1,306,385
Unrealized gain resulting from change in fair value of marketable securities		14					$ 14
Net (loss) income		6,910				6,910
Ending balance at Mar. 31, 2023		(38,233)	$ 87,140	$ 1	17,057	(55,305)	14
Ending balance, shares at Mar. 31, 2023	[1]		46,467,565	6,916,851
Beginning balance at Dec. 31, 2023		62,824		$ 6	138,657	(75,780)	(59)
Beginning balance, shares at Dec. 31, 2023				58,751,666
Issuance of common stock upon exercise of stock options		$ 250			250
Issuance of common stock upon exercise of stock options, shares		755,016		755,016
Stock-based compensation expense		$ 2,505			2,505
Issuance of common stock in connection with the acquisition of fSight		239			239
Issuance of common stock in connection with the acquisition of fSight, shares				166,271
Issuance of common stock in connection with employee incentive stock awards, shares				685,213
Unrealized gain resulting from change in fair value of marketable securities		12					12
Net (loss) income		(11,506)				(11,506)
Ending balance at Mar. 31, 2024		$ 54,324		$ 6	$ 141,651	$ (87,286)	$ (47)
Ending balance, shares at Mar. 31, 2024				60,358,166

[1] The shares of the Company’s common and redeemable convertible preferred stock prior to the Business Combination (as defined in Note 1) have been retroactively restated to reflect the exchange ratio of approximately 0.233335 established in the Business Combination as described in Note 3.